ETHER OF PHOSPHATIDYLCHOLINE AND PHOSPHATIDYLETHANOLAMINE, THEIR LYSO-FORMS AND MIXTURE THEREOF FOR USE IN THE TREATMENT OF TREATMENT OF A DISEASE OR DISORDER CAUSED BY A DEFICIENCY IN PLASMALOGENS

ETHER OF PHOSPHATIDYLCHOLINE AND PHOSPHATIDYLETHANOLAMINE, THEIR LYSO-FORMS AND MIXTURE THEREOF FOR USE IN THE TREATMENT OF TREATMENT OF A DISEASE OR DISORDER CAUSED BY A DEFICIENCY IN PLASMALOGENS

The disclosure relates to certain compounds that can be consumed by a human subject to modulate the levels of plasmalogens in the subject to provide improved health outcomes. The disclosure further relates to the formulation of said compounds, compositions comprising at least one compound, and uses...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PAUL, Sudip, MEIKLE, Peter J, BOILEAU, Amy, DUCKER, Martin, HUYHN, Kevin
Format: Patent
Sprache:eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The disclosure relates to certain compounds that can be consumed by a human subject to modulate the levels of plasmalogens in the subject to provide improved health outcomes. The disclosure further relates to the formulation of said compounds, compositions comprising at least one compound, and uses thereof. L'invention concerne certains composés qui peuvent être consommés par un sujet humain pour moduler les taux de plasmalogènes chez le sujet pour fournir des résultats améliorés en matière de santé. L'invention concerne en outre la formulation desdits composés, des compositions comprenant au moins un composé et leurs utilisations.